Ohcanbohtosat - Collin Crowley
- Čájehuvvo 1 - 3 / 3
-
1
Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis Dahkki Neeta B. Amin, Santos Carvajal‐Gonzalez, Julie J. Purkal, Tong Zhu, Collin Crowley, Sylvie Perez, Kristin Chidsey, Albert M. Kim, Bryan Goodwin
Almmustuhtton 2019Artigo -
2
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems Dahkki Trenton T. Ross, Collin Crowley, Kenneth L. Kelly, Anthony Rinaldi, David A. Beebe, Matthew P. Lech, Robert V. Martinez, Santos Carvajal‐Gonzalez, Magalie Boucher, Dinesh Hirenallur‐Shanthappa, Jeffrey Morin, Alan Opsahl, Sarah Regina Vargas, Kendra K. Bence, Jeffrey A. Pfefferkorn, William P. Esler
Almmustuhtton 2020Artigo -
3
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction Dahkki Jemy A. Gutierrez, Wei Liu, Sylvie Perez, Gang Xing, Gabriele E. Sonnenberg, Kou Kou, Matt Blatnik, Richard Allen, Yan Weng, Nicholas B. Vera, Kristin Chidsey, Arthur Bergman, Veena Somayaji, Collin Crowley, Michelle Clasquin, Anu Nigam, Melissa A. Fulham, Derek M. Erion, Trenton T. Ross, William P. Esler, Thomas V. Magee, Jeffrey A. Pfefferkorn, Kendra K. Bence, Morris J. Birnbaum, Gregory J. Tesz
Almmustuhtton 2021Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Disease
Fatty liver
Internal medicine
Medicine
Steatohepatitis
Steatosis
Biochemistry
Chemistry
Endocrinology
Insulin resistance
Lipid metabolism
Lipogenesis
Nonalcoholic fatty liver disease
Beta oxidation
Cholesterol
Diabetes mellitus
Diacylglycerol kinase
Enzyme
Fibrosis
Fructose
Hepatic stellate cell
Hyperinsulinemia
Hypertriglyceridemia
Inflammation
Insulin
Lipotoxicity
Metabolic syndrome
Metabolism
Nonalcoholic steatohepatitis